Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020 - 2021)

China SXT Pharmaceuticals (SXTC) has 2 years of Current Deferred Tax Assets data on record, last reported at $547807.0 in Q1 2021.

  • For Q1 2021, Current Deferred Tax Assets rose 7.28% year-over-year to $547807.0; the TTM value through Mar 2021 reached $547807.0, up 7.28%, while the annual FY2021 figure was $547807.0, 7.28% up from the prior year.
  • Current Deferred Tax Assets reached $547807.0 in Q1 2021 per SXTC's latest filing, up from $510617.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $547807.0 in Q1 2021 and bottomed at $510617.0 in Q1 2020.